1-20 of 21
Authors: Charles L Sentman
Journal Article
Toxicity Induced by a Bispecific T Cell–Redirecting Protein Is Mediated by Both T Cells and Myeloid Cells in Immunocompetent Mice Get access
The Journal of Immunology, Volume 204, Issue 11, June 2020, Pages 2973–2983, https://doi.org/10.4049/jimmunol.1901401
Published: 01 June 2020
Journal Article
Mechanisms of Acute Toxicity in NKG2D Chimeric Antigen Receptor T Cell–Treated Mice Get access
The Journal of Immunology, Volume 197, Issue 12, December 2016, Pages 4674–4685, https://doi.org/10.4049/jimmunol.1600769
Published: 15 December 2016
Journal Article
B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity Get access
The Journal of Immunology, Volume 194, Issue 11, June 2015, Pages 5305–5311, https://doi.org/10.4049/jimmunol.1402517
Published: 01 June 2015
Journal Article
Correction: Chimeric NKG2D T Cells Require Both T Cell- and Host-Derived Cytokine Secretion and Perforin Expression to Increase Tumor Antigen Presentation and Systemic Immunity Free
The Journal of Immunology, Volume 193, Issue 3, August 2014, Page 1513, https://doi.org/10.4049/jimmunol.1490025a
Published: 01 August 2014
Journal Article
Correction: Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-γ and GM-CSF Free
The Journal of Immunology, Volume 193, Issue 3, August 2014, Page 1513, https://doi.org/10.4049/jimmunol.1490025c
Published: 01 August 2014
Journal Article
Correction: Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment Free
The Journal of Immunology, Volume 193, Issue 3, August 2014, Page 1513, https://doi.org/10.4049/jimmunol.1490025b
Published: 01 August 2014
Journal Article
Correction: Immunotherapy with Chimeric NKG2D Receptors Leads to Long-Term Tumor-Free Survival and Development of Host Antitumor Immunity in Murine Ovarian Cancer Free
The Journal of Immunology, Volume 193, Issue 3, August 2014, Page 1513, https://doi.org/10.4049/jimmunol.1490025
Published: 01 August 2014
Journal Article
Mouse Tumor Vasculature Expresses NKG2D Ligands and Can Be Targeted by Chimeric NKG2D-Modified T Cells Get access
The Journal of Immunology, Volume 190, Issue 5, March 2013, Pages 2455–2463, https://doi.org/10.4049/jimmunol.1201314
Published: 01 March 2013
Journal Article
An NKp30-Based Chimeric Antigen Receptor Promotes T Cell Effector Functions and Antitumor Efficacy In Vivo Get access
The Journal of Immunology, Volume 189, Issue 5, September 2012, Pages 2290–2299, https://doi.org/10.4049/jimmunol.1103495
Published: 01 September 2012
Journal Article
Chimeric Antigen Receptor T Cells Shape Myeloid Cell Function within the Tumor Microenvironment through IFN-γ and GM-CSF Get access
The Journal of Immunology, Volume 188, Issue 12, June 2012, Pages 6389–6398, https://doi.org/10.4049/jimmunol.1103019
Published: 15 June 2012
Journal Article
TRAIL/DR5 Plays a Critical Role in NK Cell-Mediated Negative Regulation of Dendritic Cell Cross-Priming of T Cells Get access
The Journal of Immunology, Volume 187, Issue 6, September 2011, Pages 3087–3095, https://doi.org/10.4049/jimmunol.1003879
Published: 15 September 2011
Journal Article
Chimeric NKG2D Expressing T Cells Eliminate Immunosuppression and Activate Immunity within the Ovarian Tumor Microenvironment Get access
The Journal of Immunology, Volume 183, Issue 11, December 2009, Pages 6939–6947, https://doi.org/10.4049/jimmunol.0902000
Published: 01 December 2009
Journal Article
Chimeric NKG2D T Cells Require Both T Cell- and Host-Derived Cytokine Secretion and Perforin Expression to Increase Tumor Antigen Presentation and Systemic Immunity Get access
The Journal of Immunology, Volume 183, Issue 4, August 2009, Pages 2365–2372, https://doi.org/10.4049/jimmunol.0900721
Published: 15 August 2009
Journal Article
Vascular Endothelial Growth Factor C Facilitates Immune Tolerance and Endovascular Activity of Human Uterine NK Cells at the Maternal-Fetal Interface Get access
The Journal of Immunology, Volume 182, Issue 7, April 2009, Pages 4085–4092, https://doi.org/10.4049/jimmunol.0803769
Published: 01 April 2009
Journal Article
Immunotherapy with Chimeric NKG2D Receptors Leads to Long-Term Tumor-Free Survival and Development of Host Antitumor Immunity in Murine Ovarian Cancer Get access
The Journal of Immunology, Volume 180, Issue 1, January 2008, Pages 72–78, https://doi.org/10.4049/jimmunol.180.1.72
Published: 01 January 2008
Journal Article
NK Cells Negatively Regulate Antigen Presentation and Tumor-Specific CTLs in a Syngeneic Lymphoma Model Get access
The Journal of Immunology, Volume 178, Issue 10, May 2007, Pages 6140–6147, https://doi.org/10.4049/jimmunol.178.10.6140
Published: 15 May 2007
Journal Article
Cutting Edge: Dominance by an MHC-Independent Inhibitory Receptor Compromises NK Killing of Complex Targets Get access
The Journal of Immunology, Volume 176, Issue 12, June 2006, Pages 7165–7169, https://doi.org/10.4049/jimmunol.176.12.7165
Published: 15 June 2006
Journal Article
TLRs Mediate IFN-γ Production by Human Uterine NK Cells in Endometrium Get access
The Journal of Immunology, Volume 176, Issue 10, May 2006, Pages 6219–6224, https://doi.org/10.4049/jimmunol.176.10.6219
Published: 15 May 2006
Journal Article
Recruitment of Uterine NK Cells: Induction of CXC Chemokine Ligands 10 and 11 in Human Endometrium by Estradiol and Progesterone Get access
The Journal of Immunology, Volume 173, Issue 11, December 2004, Pages 6760–6766, https://doi.org/10.4049/jimmunol.173.11.6760
Published: 01 December 2004
Journal Article
MHC Class I-Ly49 Interactions Shape the Ly49 Repertoire on Murine NK Cells Get access
The Journal of Immunology, Volume 166, Issue 11, June 2001, Pages 6585–6592, https://doi.org/10.4049/jimmunol.166.11.6585
Published: 01 June 2001
